Project Covalence

Almost every company and non-profit working on COVID-19 that I offered to help asked for support with clinical trials—for companies focusing on developing novel drugs, vaccines, and diagnostics, rapidly spinning up trials is one of their biggest bottlenecks.

We are not affiliated with Sam Altman. This unofficial audio edition is available to listen to and share for free. Read the original post on Sam Altman's blog.